Drug or treatment

Gemtuzumab clinical trials

• 10Clinical trials
• 6Countries

Newest trials

All recruiting trials (10)

• Venetoclax or GO added to standard chemotherapy for CBF-AML

  This phase 2 trial tests whether adding venetoclax or gemtuzumab ozogamicin to the usual cytarabine/daunorubicin regimen helps people with core-binding factor AML achieve higher complete remissions without residual disease.

  Recruiting at 81 sites Phase 2 National Cancer Institute (NCI) · Birmingham, Alabama and 80 other locations · NCT06917911

• Combining ziftomenib with venetoclax and gemtuzumab for children with acute myeloid leukemia

  This study is testing a new combination of medicines for children with tough cases of acute myeloid leukemia to see if it is safe and helps them feel better.

  Recruiting Phase 1 M.D. Anderson Cancer Center · Houston, Texas · NCT06448013

• Combining CPX-351 with Gemtuzumab Ozogamicin for Newly Diagnosed AML

  This study is testing a combination of two treatments, CPX-351 and gemtuzumab ozogamicin, to see if they are safe and effective for adults with newly diagnosed acute myeloid leukemia (AML).

  Recruiting Phase 1 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT05558124

• Combining Midostaurin and Gemtuzumab Ozogamicin for Treating Acute Myeloid Leukemia

  This study is testing a new combination of two drugs to see if it can help newly diagnosed acute myeloid leukemia patients with certain genetic mutations respond better to treatment.

  Recruiting at 19 sites Phase 1/2 Technische Universität Dresden · München, Bavaria and 20 other locations · NCT04385290

• Comparing chemotherapy options for newly diagnosed acute myeloid leukemia

  This study is testing whether a new combination of treatments is better than standard chemotherapy for children and young adults with newly diagnosed acute myeloid leukemia.

  Recruiting at 188 sites Phase 3 Children's Oncology Group · Birmingham, Alabama and 205 other locations · NCT04293562

• Using Gemtuzumab with Chemotherapy for Treating Acute Myeloid Leukemia

  This study tests if adding a drug called gemtuzumab to regular chemotherapy can help people with certain types of acute myeloid leukemia have better treatment results and lower disease levels after their initial treatment.

  Recruiting at 48 sites Phase 3 Gruppo Italiano Malattie EMatologiche dell'Adulto · Alessandria and 47 other locations · NCT04168502

• Treatment for patients with difficult-to-treat acute myeloid leukemia

  This study is testing a new combination of chemotherapy drugs to see if it can help adults with tough-to-treat acute myeloid leukemia that hasn't responded to previous treatments.

  Recruiting Phase 2 University of Maryland, Baltimore · Baltimore, Maryland · NCT04050280

• Using gemtuzumab ozogamicin to treat residual disease in acute myeloid leukemia

  This study is testing if a new targeted treatment called gemtuzumab ozogamicin can help people with acute myeloid leukemia who still have leftover cancer after initial therapy.

  Recruiting Phase 2 University of Washington · Seattle, Washington · NCT03737955

• Combining tretinoin and arsenic trioxide with or without gemtuzumab ozogamicin for treating acute promyelocytic leukemia

  This study is testing a new combination of treatments for people with acute promyelocytic leukemia to see if it helps them stay healthy longer and improves their chances of recovery without causing more side effects.

  Recruiting at 5 sites Phase 2 M.D. Anderson Cancer Center · Houston, Texas and 4 other locations · NCT01409161

• Combination chemotherapy for newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndrome

  This study is testing a mix of chemotherapy drugs to see if they can help people with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome achieve remission and live longer.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT00801489

Quick answers

How many clinical trials of Gemtuzumab are recruiting right now?

10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in United States (8 trials), Puerto Rico (2 trials), Australia (1 trial), Canada (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 5, Phase 1: 2, Phase 3: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →